These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 23552692

  • 1. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.
    Jung HM, Patel RS, Phillips BL, Wang H, Cohen DM, Reinhold WC, Chang LJ, Yang LJ, Chan EK.
    Mol Biol Cell; 2013 Jun; 24(11):1638-48, S1-7. PubMed ID: 23552692
    [Abstract] [Full Text] [Related]

  • 2. CIP2A expression and localization in oral carcinoma and dysplasia.
    Katz J, Jakymiw A, Ducksworth MK, Stewart CM, Bhattacharyya I, Cha S, Chan EK.
    Cancer Biol Ther; 2010 Oct 01; 10(7):694-9. PubMed ID: 21068540
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CIP2A inhibits PP2A in human malignancies.
    Junttila MR, Puustinen P, Niemelä M, Ahola R, Arnold H, Böttzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grènman R, Kast J, Kallunki T, Sears R, Kähäri VM, Westermarck J.
    Cell; 2007 Jul 13; 130(1):51-62. PubMed ID: 17632056
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CIP2A influences survival in colon cancer and is critical for maintaining Myc expression.
    Wiegering A, Pfann C, Uthe FW, Otto C, Rycak L, Mäder U, Gasser M, Waaga-Gasser AM, Eilers M, Germer CT.
    PLoS One; 2013 Jul 13; 8(10):e75292. PubMed ID: 24098375
    [Abstract] [Full Text] [Related]

  • 9. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
    Dong QZ, Wang Y, Dong XJ, Li ZX, Tang ZP, Cui QZ, Wang EH.
    Ann Surg Oncol; 2011 Mar 13; 18(3):857-65. PubMed ID: 20842459
    [Abstract] [Full Text] [Related]

  • 10. CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.
    Niemelä M, Kauko O, Sihto H, Mpindi JP, Nicorici D, Pernilä P, Kallioniemi OP, Joensuu H, Hautaniemi S, Westermarck J.
    Oncogene; 2012 Sep 27; 31(39):4266-78. PubMed ID: 22249265
    [Abstract] [Full Text] [Related]

  • 11. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
    Khanna A, Böckelman C, Hemmes A, Junttila MR, Wiksten JP, Lundin M, Junnila S, Murphy DJ, Evan GI, Haglund C, Westermarck J, Ristimäki A.
    J Natl Cancer Inst; 2009 Jun 03; 101(11):793-805. PubMed ID: 19470954
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of CIP2A in oral squamous cell carcinoma.
    Basile JR, Czerninski R.
    Cancer Biol Ther; 2010 Oct 01; 10(7):700-2. PubMed ID: 20729627
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z, Liu D, Su Z.
    Tumour Biol; 2015 Jun 01; 36(6):4777-83. PubMed ID: 25636449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.